BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36394642)

  • 1. Brief report: STING expressed in tumor and non-tumor compartments has distinct roles in regulating anti-tumor immunity.
    Kim JC; Liu X; Fitzgerald K; Eng JS; Orf J; O'Brien SA; Belmontes B; Casbon AJ; Novitskiy SV; Tarbell KV; DeVoss J; Egen JG
    Cancer Immunol Immunother; 2023 May; 72(5):1327-1335. PubMed ID: 36394642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS-STING pathway strategies.
    Huang M; Cha Z; Liu R; Lin M; Gafoor NA; Kong T; Ge F; Chen W
    Front Immunol; 2024; 15():1399926. PubMed ID: 38817608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting STING for cancer immunotherapy: From mechanisms to translation.
    Huang R; Ning Q; Zhao J; Zhao X; Zeng L; Yi Y; Tang S
    Int Immunopharmacol; 2022 Dec; 113(Pt A):109304. PubMed ID: 36252492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy.
    Luo K; Li N; Ye W; Gao H; Luo X; Cheng B
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
    Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STING: a master regulator in the cancer-immunity cycle.
    Zhu Y; An X; Zhang X; Qiao Y; Zheng T; Li X
    Mol Cancer; 2019 Nov; 18(1):152. PubMed ID: 31679519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment.
    Kho VM; Mekers VE; Span PN; Bussink J; Adema GJ
    Cell Immunol; 2021 Apr; 362():104298. PubMed ID: 33592541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive elaboration of the cGAS-STING signaling axis in cancer development and immunotherapy.
    Zheng J; Mo J; Zhu T; Zhuo W; Yi Y; Hu S; Yin J; Zhang W; Zhou H; Liu Z
    Mol Cancer; 2020 Aug; 19(1):133. PubMed ID: 32854711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blockade.
    Yang H; Lee WS; Kong SJ; Kim CG; Kim JH; Chang SK; Kim S; Kim G; Chon HJ; Kim C
    J Clin Invest; 2019 Jul; 129(10):4350-4364. PubMed ID: 31343989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC.
    Li K; Gong Y; Qiu D; Tang H; Zhang J; Yuan Z; Huang Y; Qin Y; Ye L; Yang Y
    J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.
    Corrales L; Gajewski TF
    Clin Cancer Res; 2015 Nov; 21(21):4774-9. PubMed ID: 26373573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight into the dichotomous regulation of STING activation in immunotherapy.
    Hu Z; Yang Y; Fang L; Zhou J; Zhang H
    Immunopharmacol Immunotoxicol; 2021 Apr; 43(2):126-137. PubMed ID: 33618600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Regulation by Cytosolic DNA Sensors in the Tumor Microenvironment.
    Fukuda K
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune Regulation of the cGAS-STING Signaling Pathway in the Tumor Microenvironment and Its Clinical Application.
    Pu F; Chen F; Liu J; Zhang Z; Shao Z
    Onco Targets Ther; 2021; 14():1501-1516. PubMed ID: 33688199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. African Swine Fever Virus Armenia/07 Virulent Strain Controls Interferon Beta Production through the cGAS-STING Pathway.
    García-Belmonte R; Pérez-Núñez D; Pittau M; Richt JA; Revilla Y
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
    Li A; Yi M; Qin S; Song Y; Chu Q; Wu K
    J Hematol Oncol; 2019 Apr; 12(1):35. PubMed ID: 30935414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cGAS-STING and Cancer: Dichotomous Roles in Tumor Immunity and Development.
    Ng KW; Marshall EA; Bell JC; Lam WL
    Trends Immunol; 2018 Jan; 39(1):44-54. PubMed ID: 28830732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STING-mediated DNA sensing in cancer immunotherapy.
    Zhou X; Jiang Z
    Sci China Life Sci; 2017 Jun; 60(6):563-574. PubMed ID: 28639100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.